21
TITLE: Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer
AUTHORS: Marques, IJ; Gomes, I; Pojo, M; Pires, C; Moura, MM; Cabrera, R; Santos, C; van Ijcken, WF; Teixeira, MR ; Ramalho, JS; Leite, V; Cavaco, BM;
PUBLISHED: 2021, SOURCE: THYROID, VOLUME: 31, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 8
IN MY: ORCID
22
TITLE: Outcomes of Thyrotropin Alfa Versus Levothyroxine Withdrawal-Aided Radioiodine Therapy for Distant Metastasis of Papillary Thyroid Cancer
AUTHORS: Simoes Pereira, J; Ferreira, TC; Limbert, E; Cavaco, BM; Leite, V;
PUBLISHED: 2021, SOURCE: THYROID, VOLUME: 31, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
23
TITLE: Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer
AUTHORS: Simoes Pereira, J; Mourinho, N; Ferreira, TC; Limbert, E; Cavaco, BM; Leite, V;
PUBLISHED: 2021, SOURCE: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, VOLUME: 106, ISSUE: 10
INDEXED IN: WOS CrossRef: 19
IN MY: ORCID
24
TITLE: A case report of multiple endocrine neoplasia type 1 and autoimmune disease Coincidence or correlation?. Coincidence or correlation?  Full Text
AUTHORS: Chaves, C; da Silva, TN; Pereira, BD; Anselmo, J; Claro, I; Cavaco, BM; Saramago, A; Leite, V;
PUBLISHED: 2021, SOURCE: MEDICINE, VOLUME: 100, ISSUE: 49
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
25
TITLE: Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines  Full Text
AUTHORS: Sousa, DP; Pojo, M; Pinto, AT; Leite, V; Serra, AT; Cavaco, BM;
PUBLISHED: 2020, SOURCE: NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, VOLUME: 72, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 16
IN MY: ORCID
26
TITLE: High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma  Full Text
AUTHORS: Campos, C; Fragoso, S; Luis, R; Pinto, F; Brito, C; Esteves, S; Pataco, M; Santos, S; Machado, P; Vicente, JB; Rosa, JC; Cavaco, BM; Moura, C; Pojo, M;
PUBLISHED: 2020, SOURCE: GENES, VOLUME: 11, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 13
IN MY: ORCID
27
TITLE: The role of EIF1AX in thyroid cancer tumourigenesis and progression
AUTHORS: Simoes Pereira, J; Moura, MM; Marques, IJ; Rito, M; Cabrera, RA; Leite, V; Cavaco, BM;
PUBLISHED: 2019, SOURCE: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, VOLUME: 42, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 17
IN MY: ORCID
28
TITLE: The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines
AUTHORS: Lopes Ventura, S; Pojo, M; Matias, AT; Moura, MM; Marques, IJ; Leite, V; Cavaco, BM;
PUBLISHED: 2019, SOURCE: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, VOLUME: 42, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 17
IN MY: ORCID
29
TITLE: SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center  Full Text
AUTHORS: Donato, S; Simoes, H; Pinto, AT; Cavaco, BM; Leite, V;
PUBLISHED: 2019, SOURCE: ENDOCRINE, VOLUME: 65, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
30
TITLE: Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology  Full Text
AUTHORS: Pinto, AT; Pojo, M; Simoes Pereira, J; Roque, R; Saramago, A; Roque, L; Martins, C; Andr?, S; Cabe?adas, J; Leite, V; Cavaco, BM;
PUBLISHED: 2019, SOURCE: ENDOCRINE, VOLUME: 66, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
Page 3 of 6. Total results: 53.